75.88
前日終値:
$77.00
開ける:
$75.47
24時間の取引高:
239
Relative Volume:
0.00
時価総額:
$3.47B
収益:
$305.11M
当期純損益:
$-196.00K
株価収益率:
-11,673.08
EPS:
-0.0065
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.35%
1か月 パフォーマンス:
+2.23%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Billiontoone Inc Stock (BLLN) Company Profile
Compare BLLN vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BLLN
Billiontoone Inc
|
75.47 | 3.54B | 305.11M | -196.00K | 0 | -0.0065 |
|
TMO
Thermo Fisher Scientific Inc
|
490.68 | 182.31B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
186.29 | 132.34B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
572.65 | 45.84B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
113.90 | 31.93B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
301.88 | 29.66B | 3.17B | 642.63M | 516.49M | 10.77 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-06 | 開始されました | Guggenheim | Buy |
| 2025-12-01 | 開始されました | BTIG Research | Buy |
| 2025-12-01 | 開始されました | JP Morgan | Overweight |
| 2025-12-01 | 開始されました | Jefferies | Hold |
| 2025-12-01 | 開始されました | Piper Sandler | Overweight |
| 2025-12-01 | 開始されました | Stifel | Buy |
| 2025-12-01 | 開始されました | Wells Fargo | Equal Weight |
| 2025-12-01 | 開始されました | William Blair | Outperform |
すべてを表示
Billiontoone Inc (BLLN) 最新ニュース
BillionToOne Inc (BLLN) Shares Up 3.33% on Mar 25 - GuruFocus
Why BillionToOne, Inc. Class A Shares Are Sinking - TipRanks
BillionToOne, Inc.(NasdaqGS: BLLN) added to S&P Global BMI Index - marketscreener.com
BLLN Technical Analysis | Trend, Signals & Chart Patterns | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill
Top Billiontoone (BLLN) Competitors 2026 - MarketBeat
Piper Sandler reiterates BillionToOne stock rating on NIPT tech By Investing.com - Investing.com Nigeria
Piper Sandler reiterates BillionToOne stock rating on NIPT tech - Investing.com
Billiontoone (BLLN) Stock Trends and Sentiment 2026 $BLLN - MarketBeat
Billiontoone (BLLN) Stock Forecast and Price Target 2026 $BLLN - MarketBeat
BillionToOne (NASDAQ: BLLN) Shares Climb 8% Amid Strong Momentum in Precision Diagnostics Sector - International Business Times Australia
BTIG lowers BillionToOne stock price target on valuation multiples - Investing.com Nigeria
BillionToOne, Inc.: Fundamental Analysis and Financial Ratings | BLLN | US0901681058 - marketscreener.com
BillionToOne Inc (BLLN) Shares Up 6.14% on Mar 13 - GuruFocus
BillionToOne’s Single-Molecule Next-Generation Sequencing Platform Redefines Molecular Diagnostics for Prenatal and Oncology Care 404148 - Minichart
BillionToOne 10-K: Revenue $305.1M, EPS $0.14 - TradingView
Billiontoone (NASDAQ:BLLN) Hits New 1-Year LowHere's What Happened - MarketBeat
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), BillionToOne, Inc. Class A (BLLN) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Billiontoone, Inc. (NASDAQ:BLLN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
BillionToOne Medicare Win Puts North Star Economics In Focus - Yahoo Finance
BillionToOne Market Share Gains Raise Questions On Undervalued BLLN Stock - simplywall.st
BLLN (BillionToOne) PB Ratio : (As of Mar. 07, 2026) - GuruFocus
Wall Street Zen Upgrades Billiontoone (NASDAQ:BLLN) to "Buy" - MarketBeat
BillionToOne (BLLN) Turns Profitable As Q4 EPS And Margins Challenge Bearish Narratives - simplywall.st
BillionToOne: Delivering And Lagging At The Same Time (NASDAQ:BLLN) - Seeking Alpha
Analysts Are Bullish on These Healthcare Stocks: BillionToOne, Inc. Class A (BLLN), Concentra Group Holdings Parent, Inc. (CON) - The Globe and Mail
What Makes BillionToOne (BLLN) an Attractive Bet? - Yahoo Finance
BTIG Maintains Buy on BillionToOne, Inc. (BLLN) March 2026 - Meyka
Billiontoone (NASDAQ:BLLN) Sees Large Volume Increase on Better-Than-Expected Earnings - MarketBeat
BillionToOne Q4 2025 Results: Profit & Revenue Surpass ForecastsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Assessing BillionToOne (BLLN) Valuation After Recent Share Price Volatility - simplywall.st
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge By Investing.com - Investing.com Nigeria
Wells Fargo & Company Has Lowered Expectations for Billiontoone (NASDAQ:BLLN) Stock Price - MarketBeat
BTIG lowers BillionToOne stock price target on valuation multiples By Investing.com - Investing.com India
Billiontoone's (BLLN) "Buy" Rating Reiterated at Guggenheim - MarketBeat
Billiontoone (NASDAQ:BLLN) Price Target Lowered to $140.00 at BTIG Research - MarketBeat
BLLN: BTIG Analyst Lowers Price Target Amid Maintained 'Buy' Rat - GuruFocus
BillionToOne Swings To Profit In Q4; Lifts FY26 Guidance - Nasdaq
Billiontoone (NASDAQ:BLLN) Announces Earnings Results - MarketBeat
Billiontoone Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: BillionToOne’s Q4 2025 sees robust growth, stock dips - Investing.com India
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge - Investing.com
BillionToOne (BLLN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
BillionToOne Raises 2026 Guidance, Aligns Incentive Plan - TipRanks
BillionToOne: Q4 Earnings Snapshot - marketscreener.com
BillionToOne Q4 Swings to Profit, Revenue Rises; Increases 2026 Revenue Guidance - marketscreener.com
(BLLN) BillionToOne Expects 2026 Revenue Range $430M-$445M, vs. FactSet Est of $405.1M - marketscreener.com
Earnings Flash (BLLN) BillionToOne Posts Q4 EPS $0.11, vs. FactSet Est of $0.06 - marketscreener.com
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q4 Revenue $96.1M, vs. FactSet Est of $87.2M - marketscreener.com
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance - GlobeNewswire
Billiontoone (NASDAQ:BLLN) Trading Down 5.7%Time to Sell? - MarketBeat
BillionToOne Inc (BLLN) Trading Down 6.28% on Mar 4 - GuruFocus
Billiontoone Inc (BLLN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):